Literature DB >> 25956796

Pazopanib: a new drug for pancreatic neuroendocrine tumours.

Dik J Kwekkeboom1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25956796     DOI: 10.1016/S1470-2045(15)70200-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis.

Authors:  Alberto Bongiovanni; Chiara Liverani; Federica Recine; Valentina Fausti; Laura Mercatali; Alessandro Vagheggini; Chiara Spadazzi; Giacomo Miserocchi; Claudia Cocchi; Giandomenico Di Menna; Alessandro De Vita; Stefano Severi; Silvia Nicolini; Toni Ibrahim
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.